News
Hosted on MSN8mon
Globus Medical slips after FDA warningGlobus Medical (NYSE:GMED) shares traded down after the U.S. Food and Drug Administration (FDA) issued a warning letter to the company CEO, Daniel Scavilla, citing violations related to MedTech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback